1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13737715 2023-12-01 2025-03-31 13737715 2025-03-31 13737715 2023-11-30 13737715 2022-12-01 2023-11-30 13737715 2023-11-30 13737715 2022-11-30 13737715 core:FurnitureFittings 2023-12-01 2025-03-31 13737715 bus:Director1 2023-12-01 2025-03-31 13737715 core:LandBuildings core:OwnedOrFreeholdAssets 2023-11-30 13737715 core:FurnitureFittings 2023-11-30 13737715 core:LandBuildings core:OwnedOrFreeholdAssets 2025-03-31 13737715 core:FurnitureFittings 2025-03-31 13737715 core:AfterOneYear 2025-03-31 13737715 core:AfterOneYear 2023-11-30 13737715 core:WithinOneYear 2025-03-31 13737715 core:ShareCapital 2025-03-31 13737715 core:ShareCapital 2023-11-30 13737715 core:RetainedEarningsAccumulatedLosses 2025-03-31 13737715 core:RetainedEarningsAccumulatedLosses 2023-11-30 13737715 core:LandBuildings core:OwnedOrFreeholdAssets 2023-11-30 13737715 core:FurnitureFittings 2023-11-30 13737715 bus:SmallEntities 2023-12-01 2025-03-31 13737715 bus:AuditExemptWithAccountantsReport 2023-12-01 2025-03-31 13737715 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2025-03-31 13737715 bus:PrivateLimitedCompanyLtd 2023-12-01 2025-03-31 13737715 bus:FullAccounts 2023-12-01 2025-03-31
COMPANY REGISTRATION NUMBER: 13737715
MMP Property Investments Limited
Filleted Unaudited Financial Statements
31 March 2025
MMP Property Investments Limited
Statement of Financial Position
31 March 2025
31 Mar 25
30 Nov 23
Note
£
£
Fixed assets
Tangible assets
5
838,727
838,376
Current assets
Cash at bank and in hand
61,530
29,952
Creditors: amounts falling due within one year
6
1,080
--------
--------
Net current assets
60,450
29,952
---------
---------
Total assets less current liabilities
899,177
868,328
Creditors: amounts falling due after more than one year
7
949,686
893,437
---------
---------
Net liabilities
( 50,509)
( 25,109)
---------
---------
Capital and reserves
Called up share capital
400
400
Profit and loss account
( 50,909)
( 25,509)
--------
--------
Shareholders deficit
( 50,509)
( 25,109)
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
MMP Property Investments Limited
Statement of Financial Position (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 4 August 2025 , and are signed on behalf of the board by:
Dr Marina Parton
Director
Company registration number: 13737715
MMP Property Investments Limited
Notes to the Financial Statements
Period from 1 December 2023 to 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 46 Syon Lane, Osterley, Middlesex, TW7 5NQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures and fittings
-
10% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 (2023: 1 ).
5. Tangible assets
Freehold property
Fixtures and fittings
Total
£
£
£
Cost
At 1 December 2023
827,787
11,765
839,552
Additions
1,567
1,567
---------
--------
---------
At 31 March 2025
827,787
13,332
841,119
---------
--------
---------
Depreciation
At 1 December 2023
1,176
1,176
Charge for the period
1,216
1,216
---------
--------
---------
At 31 March 2025
2,392
2,392
---------
--------
---------
Carrying amount
At 31 March 2025
827,787
10,940
838,727
---------
--------
---------
At 30 November 2023
827,787
10,589
838,376
---------
--------
---------
6. Creditors: amounts falling due within one year
31 Mar 25
30 Nov 23
£
£
Other creditors
1,080
-------
----
7. Creditors: amounts falling due after more than one year
31 Mar 25
30 Nov 23
£
£
Bank loans and overdrafts
488,751
Other creditors
949,686
404,686
---------
---------
949,686
893,437
---------
---------
8. Related party transactions
The company was under the control of Dr. Marina Parton throughout the current financial period. Dr. Parton is the Managing Director and holds 100% of the company’s issued share capital. Included within other creditors is a loan of £949,686 (2023: £404,686) owed to MMP Oncology Limited. Dr. Marina Parton is also a director of MMP Oncology Limited and, together with her family, holds 100% of its issued share capital.